Berlex Climara adds new doses
Executive Summary
Berlex' Climara estradial hormone patch approved in .0375 mg and .06 mg doses. The once weekly patch was previously available in .025 mg, .05 mg, .075 mg and 1 mg doses. New doses will allow more options in choosing "lowest effective dose" of hormone therapy, Berlex says...
You may also be interested in...
Probiotics And Cold Remedies Boost Recordati In 2023
Italy's Recordati saw its OTC sales grow by 10% in 2023 driven by the recovery of the cough & cold market and a growing demand for probiotics.
Falling Sales Force New Priorities At Roche
The Swiss major brings a new ruthlessness to the compounds in its pipeline: if they’re not first or best, they’re out.
Human Cell-Secreted Proteins Offer A Wellspring Of Potential Therapeutics
CEO Hanadie Yousef leads Juvena Therapeutics in utilizing an AI-based platform that analyzes cell-secreted proteins to identify potential therapeutics. One of their first near-clinical assets could complement GLP-1s.